Endo ERN
Find an expert
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

890 publication(s) found matching the search criteria

Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus


Author(s): Sciammarella C, Luce A, Riccardi F, Mocerino C, Modica R, Berretta M, Misso G, Cossu AM, Colao A, Vitale G, Necas A, Fedacko J, Galdiero M, Correale P, Faggiano A, Caraglia M, Capasso A, Grimaldi A
Affiliated Institution / ERN:
Condition / Disease:
Publication: Frontiers in Oncology v10 Year: 2020 ORPHAcode / other:
DOI: 10.3389/fonc.2020.01047 Keywords: cytokines,drug-resistance,mTOR–mammalian target of rapamycin,neuroendocrine tumors,somatostatin analogs

Familial Dysalbuminemic Hyperthyroxinemia: An Underdiagnosed Entity


Author(s): Dieu X, Bouzamondo N, Briet C, Illouz F, Moal V, Boux de Casson F, Bouhours-Nouet N, Reynier P, Coutant R, Rodien P, Mirebeau-Prunier D
Affiliated Institution / ERN: IRCCS Ospedale Policlinico San Martino – Genova ;
Condition / Disease: Thyroid hormone resistance syndromes
Publication: Journal of Clinical Medicine v9.7 p2105 Year: 2020 ORPHAcode / other: ORPHA596426
DOI: 10.3390/jcm9072105 Keywords: THRB,albumin,familial dysalbuminemic hyperthyroxinemia,immunoassay interference,resistance to thyroid hormone
MTG8

Rare Germline DICER1 Variants in Pediatric Patients With Cushing’s Disease: What Is Their Role?


Author(s): Martínez de LaPiscina I, Hernández-Ramírez LC, Portillo N, Gómez-Gila AL, Urrutia I, Martínez-Salazar R, García-Castaño A, Aguayo A, Rica I, Gaztambide S, Faucz FR, Keil MF, Lodish MB, Quezado M, Pankratz N, Chittiboina P, Lane J, Kay DM, Mills JL, Castaño L, Stratakis CA
Affiliated Institution / ERN:
Condition / Disease: Cushing disease
Publication: Frontiers in Endocrinology v11 Year: 2020 ORPHAcode / other: ORPHA96253
DOI: 10.3389/fendo.2020.00433 Keywords: Cushing's disease,DICER1,corticotropinoma,disease-modifying gene,pituitary neuroendocrine tumor
MTG6

Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study


Author(s): Stefan Groeneweg, Ferdy S van Geest, Prof Ayhan Abacı, Alberto Alcantud, Gautem P Ambegaonkar, Christine M Armour, Priyanka Bakhtiani, Diana Barca, Prof Enrico S Bertini, Ingrid M van Beynum, Prof Nicola Brunetti-Pierri, Marianna Bugiani, Marco Cappa, Gerarda Cappuccio, Barbara Castellotti, Claudia Castiglioni, Prof Krishna Chatterjee, Irenaeus F M de Coo, Prof Régis Coutant, Prof Dana Craiu, Patricia Crock, Christian DeGoede, Korcan Demir, Alice Dica, Prof Paul Dimitri, Anna Dolcetta-Capuzzo, Marjolein H G Dremmen, Rachana Dubey, Anina Enderli, Jan Fairchild, Jonathan Gallichan, Belinda George, Evelien F Gevers, Annette Hackenberg, Zita Halász, Bianka Heinrich, Tony Huynh, Anna Kłosowska, Prof Marjo S van der Knaap, Marieke M van der Knoop, Prof Daniel Konrad, David A Koolen, Prof Heiko Krude, Amy Lawson-Yuen, Prof Jan Lebl, Michaela Linder-Lucht, Cláudia F Lorea, Charles M Lourenço, Roelineke J Lunsing, Greta Lyons, Jana Malikova, Edna E Mancilla, Anne McGowan, Prof Veronica Mericq, Felipe M Lora, Carla Moran, Katalin E Müller, Isabelle Oliver-Petit, Laura Paone, Praveen G Paul, Prof Michel Polak, Francesco Porta, Fabiano O Poswar, Christina Reinauer, Klara Rozenkova, Tuba S Menevse, Peter Simm, Anna Simon, Yogen Singh, Marco Spada, Jet van der Spek, Milou A M Stals, Athanasia Stoupa, Gopinath M Subramanian, Davide Tonduti, Prof Serap Turan, Corstiaan A den Uil, Joel Vanderniet, Adri van der Walt, Prof Jean-Louis Wémeau, Jolante Wierzba, Marie-Claire Y de Wit, Nicole I Wolf, Michael Wurm, Federica Zibordi, Prof Amnon Zung, Nitash Zwaveling-Soonawala, W Edward Visser
Affiliated Institution / ERN:
Condition / Disease: MCT8 deficiency
Publication: The Lancet Diabetes & Endocrinology Vol 8, Issue 7, P594-605 Year: 2020 ORPHAcode / other: ORPHA59
DOI: 10.1016/S2213-8587(20)30153-4 Keywords: MCT8 deficiency; underlying risk factors; clinical management; therapies;
MTG8

Residual Corticosteroid Production in Autoimmune Addison Disease


Author(s): Sævik ÃB, Åkerman A, Methlie P, Quinkler M, Jørgensen AP, Höybye C, Debowska AJ, Nedrebø BG, Dahle AL, Carlsen S, Tomkowicz A, Sollid ST, Nermoen I, Grønning K, Dahlqvist P, Grimnes G, Skov J, Finnes T, Valland SF, Wahlberg J, Holte SE, Simunkova K, Kämpe O, Husebye ES, Bensing S, øksnes M
Affiliated Institution / ERN:
Condition / Disease: Addison Disease
Publication: The Journal of Clinical Endocrinology & Metabolism v105.7 p2430-2441 Year: 2020 ORPHAcode / other: ORPHA85138
DOI: 10.1210/clinem/dgaa256 Keywords: Adrenal failure,Autoimmune Addison disease,adrenal steroids,cortisol,primary adrenal insufficiency,residual function
MTG1

Diagnosis of Flier’s syndrome in a patient with nondiabetic hypoglycemia: a case report and critical appraisal of the literature


Author(s): Cimmino I, Faggiano A, Perruolo G, Modica R, Bottiglieri F, Covelli B, Colao A, Beguinot F, Formisano P, Oriente F
Affiliated Institution / ERN:
Condition / Disease: Flier's syndrome
Publication: Endocrine v69.1 p73-78 Year: 2020 ORPHAcode / other: ORPHA411593
DOI: 10.1007/s12020-020-02287-4 Keywords: Autoimmune disease,Flier’s syndrome,Hirata’s disease,Hypoglycemia,Insulin signaling
MTG3

Early versus late initiation of GH replacement in adult-onset hypopituitarism


Author(s): Postma MR, Burman P, van Beek AP
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Acquired pituitary hormone deficiency
Publication: Endocrine Connections v9.7 p687-695 Year: 2020 ORPHAcode / other: ORPHA95502
DOI: 10.1530/ec-20-0098 Keywords: adult-onset growth hormone deficiency,growth hormone replacement therapy,hypopituitarism,treatment initiation
MTG6

Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI


Author(s): Theruvath AJ, Siedek F, Muehe AM, Garcia-Diaz J, Kirchner J, Martin O, Link MP, Spunt S, Pribnow A, Rosenberg J, Herrmann K, Gatidis S, Schäfer JF, Moseley M, Umutlu L, Daldrup-Link HE
Affiliated Institution / ERN: CHU de Toulouse ; Centre Hospitalier de Luxembourg ; ERN BOND ;
Condition / Disease: Treatment, Pedatric Tumours
Publication: Radiology v296.1 p143-151 Year: 2020 ORPHAcode / other:
DOI: 10.1148/radiol.2020192508 Keywords:
MTG4

Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health


Author(s): Olsson LM, Poitou C, Tremaroli V, Coupaye M, Aron-Wisnewsky J, Bäckhed F, Clément K, Caesar R
Affiliated Institution / ERN:
Condition / Disease: Prader-Willi syndrome
Publication: Gut v69.7 p1229-1238 Year: 2020 ORPHAcode / other: ORPHA739
DOI: 10.1136/gutjnl-2019-319322 Keywords: diabetes mellitus,glucose metabolism,intestinal bacteria
MTG5

Nutrigenetics—personalized nutrition in obesity and cardiovascular diseases


Author(s): Barrea L, Annunziata G, Bordoni L, Muscogiuri G, Colao A, Savastano S
Affiliated Institution / ERN:
Condition / Disease:
Publication: International Journal of Obesity Supplements v10.1 p1-13 Year: 2020 ORPHAcode / other:
DOI: 10.1038/s41367-020-0014-4 Keywords:

Commentary: Obesity: The “Achilles heel” for COVID-19?


Author(s): Muscogiuri G, Pugliese G, Barrea L, Savastano S, Colao A
Affiliated Institution / ERN:
Condition / Disease:
Publication: Metabolism v108 p154251 Year: 2020 ORPHAcode / other:
DOI: 10.1016/j.metabol.2020.154251 Keywords: COVID-19,Coronavirus,Obesity,Pneumonia

New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists


Author(s): Barrea L, Pugliese G, Muscogiuri G, Laudisio D, Colao A, Savastano S
Affiliated Institution / ERN:
Condition / Disease: Obesity
Publication: Minerva Endocrinologica v45.2 Year: 2020 ORPHAcode / other: 5B81.00
DOI: 10.23736/S0391-1977.20.03179-X Keywords:

Genetic testing in inherited endocrine disorders, Joint position paper of the European Reference Network on Rare Endocrine Diseases (Endo-ERN)


Author(s): Eggermann T, Elbracht M, Kurth I, Juul A, Holm Johannsen T, Netchine I, Mastorakos G, Johannsson G, Musholt TJ, Zenker M, Prawitt D, Pereira AM, Hiort O
Affiliated Institution / ERN: Copenhagen University Hospital, Rigshospitalet ; Sahlgrenska University Hospital ; University Medical Center Mainz ; Leiden University Medical Center ; Universitätsklinikum Schleswig-Holstein ; Universitätsklinikum Magdeburg ; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ;
Condition / Disease: Inherited endocrine disorders
Publication: Orphanet Journal of Rare Diseases 2020, 15:144 Year: 2020 ORPHAcode / other: ORPHA97978
DOI: 10.1186/s13023-020-01420-w Keywords: Genetic testing; Imprinting disorders; Rare endocrine conditions; Short stature; glucose and insulin homeostasis; Hypogonadotropic hypogonadism; differences/disorders of sex development;
MTG1 MTG2 MTG3 MTG4 MTG5 MTG6 MTG7 MTG8

Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions


Author(s): Nunzia Prencipe, Mirko Parasiliti-Caprino, Filippo Gatti, Federica Penner, Alessandro Maria Berton, Chiara Bona, Marina Caputo, Valentina D'Angelo, Vincenzo Cappiello, Valentina Gasco, Ezio Ghigo, Francesco Zenga, Silvia Grottoli
Affiliated Institution / ERN: AO City of Health and Science - Turin ;
Condition / Disease: Adrenal Insufficiency
Publication: Karger Doi: 10.1159/000509092 Year: 2020 ORPHAcode / other: ORPHA101958
DOI: 10.1159/000509092 Keywords: Adrenal insufficiency; Neurosurgery; Pituitary surgery; Pituitary tumors; Pituitary-adrenal system;
MTG1 MTG6

Hypocalcemia induced by tyrosine kinase inhibitors: targeted treatment with ‘untargeted’ side effects


Author(s): Berends AMA, van der Horst-Schrivers ANA, Oosting SF, Kapiteijn EW, de Groot JWB, Links TP
Affiliated Institution / ERN:
Condition / Disease: Hypocalcemia
Publication: Acta Oncologica v59.6 p726-729 Year: 2020 ORPHAcode / other: 5B5K.1Z
DOI: 10.1080/0284186X.2020.1726455 Keywords:
MTG2

Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature


Author(s): Sadowski SM, Pieterman CRC, Perrier ND, Triponez F, Valk GD
Affiliated Institution / ERN:
Condition / Disease: Multiple endocrine neoplasia type 1
Publication: Endocrine-Related Cancer v27.6 pR145-R161 Year: 2020 ORPHAcode / other: ORPHA652
DOI: 10.1530/ERC-19-0372 Keywords: MEN1,metastases,nonfunctioning pancreatic neuroendocrine tumors,prognostic factors,survival,systematic review
MTG4

Long-term Metabolic and Socioeducational Outcomes of Transient Neonatal Diabetes: A Longitudinal and Cross-sectional Study


Author(s): Le Bourgeois F, Beltrand J, Baz B, Julla J, Riveline J, Simon A, Flechtner I, Ait Djoudi M, Fauret-Amsellem A, Vial Y, Scharfmann R, Sommet J, Boudou P, Cavé H, Polak M, Gautier J, Busiah K, Abu-Amara Olivieri S, Bachere N, Bellanne-Chantelot C, Bertrand A, Bourron O, De Boisvilliers F, Deumier B, Gourdy P, Hartemann A, Jellimann S, Le Tallec C, Martin-Dessilla A, Paoli A, Perrin M, Ribstein J, Saint-Martin C, Thivolet C, Vialettes B, Ythier H
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Cochin ;
Condition / Disease: Transient Neonatel Diabetes mellitus
Publication: Diabetes Care v43.6 p1191-1199 Year: 2020 ORPHAcode / other: ORPHA99886
DOI: 10.2337/dc19-0324 Keywords:
MTG3

FGF23-related hypophosphatemia in patients with low bone mineral density and fragility fractures: challenges in diagnosis and management


Author(s): Indirli R, Guabello G, Longhi M, Niada S, Maruca K, Mora S, Maggioni M, Corbetta S
Affiliated Institution / ERN:
Condition / Disease: X-linked hypophosphataemia
Publication: Journal of Endocrinological Investigation v43.6 p787-798 Year: 2020 ORPHAcode / other: ORPHA89936
DOI: 10.1007/s40618-019-01165-9 Keywords: Fibroblast growth factor 23,Hypophosphatemia,Low bone mineral density,Skeletal fragility,Tumor-induced osteomalacia
MTG2

The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism


Author(s): Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, Concistrè A, Del Pinto R, Fabris B, Fallo F, Fava C, Ferri C, Giacchetti G, Grassi G, Letizia C, Maccario M, Mallamaci F, Maiolino G, Manfellotto D, Minuz P, Monticone S, Morganti A, Muiesan ML, Mulatero P, Negro A, Parati G, Pengo MF, Petramala L, Pizzolo F, Rizzoni D, Rossitto G, Veglio F, Seccia TM
Affiliated Institution / ERN:
Condition / Disease: Primary aldosteronism
Publication: International Journal of Cardiology Hypertension v5 p100029 Year: 2020 ORPHAcode / other: ORPHA181415
DOI: 10.1016/j.ijchy.2020.100029 Keywords: Diagnosis,Guidelines,Hypertension,Primary aldosteronism,Treatment
MTG1

Adrenalectomy for Primary Aldosteronism: Significant Variability in Work‐Up Strategies and Low Guideline Adherence in Worldwide Daily Clinical Practice


Author(s): Vorselaars WMCM, van Beek D, Suurd DPD, Postma E, Spiering W, Borel Rinkes IHM, Valk GD, Vriens MR, Zarnegar R, Fahey TJ, Drake FT, Duh QY, Talutis SD, McAneny DB, McManus C, Lee JA, Grant SB, Grogan RH, Romero Arenas MA, Perrier ND, Sturgeon C, Castelino T, Mitmaker EJ, Parente DN, Pasternak JD, Sidhu SB, Sywak M, D'Amato G, Raffaelli M, Schuermans V, Bouvy ND, Eker HH, Jaap Bonjer H, Engelsman AF, Nieveen van Dijkum EJM, Kerstens MN, Kruijff S
Affiliated Institution / ERN:
Condition / Disease: Primary aldosteronism
Publication: World Journal of Surgery v44.6 p1905-1915 Year: 2020 ORPHAcode / other: ORPHA181415
DOI: 10.1007/s00268-020-05408-2 Keywords:
MTG1

Peptide hormone analysis in diagnosis and treatment of Differences of Sex Development: joint position paper of EU COST Action ‘DSDnet’ and European Reference Network on Rare Endocrine Conditions.


Author(s): Johannsen TH, Andersson AM, Ahmed SF, de Rijke YB, Greaves RF, Hartmann MF, Hiort O, Holterhus PM, Krone NP, Kulle A, Ljubicic ML, Mastorakos G, McNeilly J, Pereira AM, Saba A, Wudy SA, Main KM, Juul A
Affiliated Institution / ERN: AOU Pisan ; Leiden University Medical Center ; General Hospital of Athens “LAIKO” ; Universitätsklinikum Schleswig-Holstein ; Erasmus MC: University Medical Center Rotterdam ; Copenhagen University Hospital, Rigshospitalet ;
Condition / Disease: DSD
Publication: European Journal of Endocrinology Volume 182: Issue 6 Page(s): P1–P15 Year: 2020 ORPHAcode / other: ORPHA90771
DOI: 10.1530/EJE-19-0831 Keywords: DSD; peptide hormone analyses; COST DSDnet; Endo-ERN;
MTG7

Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study


Author(s): Larsen LV, Mirebeau-Prunier D, Imai T, Alvarez-Escola C, Hasse-Lazar K, Censi S, Castroneves LA, Sakurai A, Kihara M, Horiuchi K, Barbu VD, Borson-Chazot F, Gimenez-Roqueplo A, Pigny P, Pinson S, Wohllk N, Eng C, Aydogan BI, Saranath D, Dvorakova S, Castinetti F, Patocs A, Bergant D, Links TP, Peczkowska M, Hoff AO, Mian C, Dwight T, Jarzab B, Neumann HPH, Robledo M, Uchino S, Barlier A, Godballe C, Mathiesen JS
Affiliated Institution / ERN:
Condition / Disease: Multiple endocrine neoplasia type 2A
Publication: Endocrine Connections v9.6 p489-497 Year: 2020 ORPHAcode / other: ORPHA247698
DOI: 10.1530/EC-20-0163 Keywords: RET,medullary thyroid carcinoma,multiple endocrine neoplasia type 2A,pheochromocytoma,primary hyperparathyroidism
MTG4

Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly


Author(s): van der Lely AJ, Kuhn E, Muhammad A, Coopmans EC, Neggers SJ, Chanson P
Affiliated Institution / ERN: Erasmus MC: University Medical Center Rotterdam ; Hôpital Bicêtre ;
Condition / Disease: Acromegaly
Publication: European Journal of Endocrinology v182.6 pD17-D29 Year: 2020 ORPHAcode / other: ORPHA963
DOI: 10.1530/EJE-19-0998 Keywords:
MTG6

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly


Author(s): Coopmans EC, Schneiders JJ, El-Sayed N, Erler NS, Hofland LJ, van der Lely A, Petrossians P, Potorac J, Muhammad A, Neggers SJCMM
Affiliated Institution / ERN: Erasmus MC: University Medical Center Rotterdam ; University Hospital Liège ;
Condition / Disease: Acromegaly
Publication: European Journal of Endocrinology v182.6 p595-605 Year: 2020 ORPHAcode / other: ORPHA963
DOI: 10.1530/EJE-19-0840 Keywords:
MTG6

Characterization of the stem cell niche components within the seminiferous tubules in testicular biopsies of Klinefelter patients


Author(s): Van Saen D, Vloeberghs V, Gies I, De Schepper J, Tournaye H, Goossens E
Affiliated Institution / ERN:
Condition / Disease: Klinefelter Syndrome
Publication: Fertility and Sterility v113.6 p1183-1195.e3 Year: 2020 ORPHAcode / other: Q98.4
DOI: 10.1016/j.fertnstert.2020.01.018 Keywords: Extracellular matrix,Klinefelter syndrome,infertility,peritubular myoid cells,tubular integrity
MTG7

Germ cell loss in Klinefelter syndrome: When and why?


Author(s): Willems M, Gies I, Van Saen D
Affiliated Institution / ERN:
Condition / Disease: Klinefelter Syndrome
Publication: American Journal of Medical Genetics Part C: Seminars in Medical Genetics v184.2 p356-370 Year: 2020 ORPHAcode / other: Q98.4
DOI: 10.1002/ajmg.c.31787 Keywords: Klinefelter syndrome,X-linked gene expression,aneuploidy,germ cell loss,infertility
MTG7

Gonadal dysfunction and beyond: Clinical challenges in children, adolescents, and adults with 47,XXY Klinefelter syndrome


Author(s): Zitzmann M, Rohayem J
Affiliated Institution / ERN:
Condition / Disease: Klinefelter Syndrome
Publication: American Journal of Medical Genetics Part C: Seminars in Medical Genetics v184.2 p302-312 Year: 2020 ORPHAcode / other: LD50.31
DOI: 10.1002/ajmg.c.31786 Keywords: 47,XXY,Klinefelter syndrome,children with Klinefelter syndrome,fertility in Klinefelter syndrome,hypogonadism in Klinefelter syndrome
MTG7

Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study


Author(s): Colao A, Bronstein MD, Brue T, De Marinis L, Fleseriu M, Guitelman M, Raverot G, Shimon I, Fleck J, Gupta P, Pedroncelli AM, Gadelha MR
Affiliated Institution / ERN:
Condition / Disease: Acromegaly
Publication: European Journal of Endocrinology v182.6 p583 Year: 2020 ORPHAcode / other: ORPHA963
DOI: 10.1530/EJE-19-0762 Keywords:
MTG6

Psychological Distress and Illness Perceptions in Thyroid Cancer Survivors: Does Age Matter?


Author(s): Husson O, Poort H, Sansom-Daly UM, Netea-Maier R, Links T, Mols F
Affiliated Institution / ERN:
Condition / Disease: Thyroid cancers
Publication: Journal of Adolescent and Young Adult Oncology v9.3 p375-383 Year: 2020 ORPHAcode / other: ORPHA100088
DOI: 10.1089/jayao.2019.0153 Keywords: age,illness perceptions,psychological distress,thyroid cancer
MTG8

Thyroid gland changes in patients with acromegaly


Author(s): Emil Natchev, Silvia Vandeva, Roussanka Kovatcheva, Georgi Kirilov, Krasimir Kalinov, Sabina Zacharieva
Affiliated Institution / ERN:
Condition / Disease: Acromegaly
Publication: Arch Endocrinol Metab 64(3):269-275 Year: 2020 ORPHAcode / other: ORPHA963
DOI: 10.20945/2359-3997000000247 Keywords: Thyroid volume; acromegaly; disease activity; secondary hypothyroidism; nodular goiter;
MTG6
Page 27 of 30« First«...1020...2526272829...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2025. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance